NDC 60492-0075
BAT
Botulism Antitoxin Heptavalent
BAT is a Intravenous Liquid in the Plasma Derivative category. It is labeled and distributed by Emergent Biosolutions Canada Inc.. The primary component is Equine Botulinum Neurotoxin A Immune Fab2; Equine Botulinum Neurotoxin B Immune Fab2; Equine Botulinum Neurotoxin C Immune Fab2; Equine Botulinum Neurotoxin D Immune Fab2; Equine Botulinum Neurotoxin E Immune Fab2; Equine Botulinum Neurotoxin F Immune Fab2; Equine Botulinum Neurotoxin G Immune Fab2.
| Product ID | 60492-0075_35d3ee15-d4d5-4fba-9c03-b5a625c5048d |
| NDC | 60492-0075 |
| Product Type | Plasma Derivative |
| Proprietary Name | BAT |
| Generic Name | Botulism Antitoxin Heptavalent |
| Dosage Form | Liquid |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2013-03-01 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125462 |
| Labeler Name | Emergent BIoSolutions Canada Inc. |
| Substance Name | EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2 |
| Active Ingredient Strength | 4500 [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |